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Abstract
Heteromultimerization of Kir4.1 and Kir5.1 leads to a channel with distinct functional properties. The heteromeric Kir4.1–Kir5.1 channel is
expressed in the eye, kidney and brainstem and has CO2/pH sensitivity in the physiological range, suggesting a candidate molecule for the
regulation of K+ homeostasis and central CO2 chemoreception. It is known that K
+ transport in renal epithelium and brainstem CO2
chemosensitivity are subject to modulation by hormones and neurotransmitters that activate distinct intracellular signaling pathways. If the
Kir4.1–Kir5.1 channel is involved in pH-dependent regulation of cellular functions, it may also be regulated by some of the intracellular signaling
systems. Therefore, we undertook studies to determine whether PKC modulates the heteromeric Kir4.1–Kir5.1 channel. The channel expressed
using a Kir4.1–Kir5.1 tandem dimer construct was inhibited by the PKC activator PMA in a dose-dependent manner. The channel inhibition was
produced via reduction of the Popen. The effect of PMA was abolished by specific PKC inhibitors. In contrast, exposure of oocytes to forskolin
(a PKA activator) had no significant effect on Kir4.1–Kir5.1 currents. The channel inhibition appeared to be independent of PIP2 depletion and
PKC-dependent internalization. Several consensus sequences of potential PKC phosphorylation sites were identified in the Kir4.1 and Kir5.1
subunits by sequence scan. Although the C-terminal peptides of both Kir4.1 and Kir5.1 were phosphorylated in vitro, site-directed mutagenesis of
individual residues failed to reveal the PKC phosphorylation sites suggesting that the channel may have multiple phosphorylation sites. Taken
together, these results suggest that the Kir4.1–Kir5.1 but not the homomeric Kir4.1 channel is strongly inhibited by PKC activation.
Published by Elsevier B.V.Keywords: Kir4.1–Kir5.1; Protein kinase C; Phosphorylation; Endocytosis1. Introduction
The inward rectifier K+ channels (Kir) control membrane
potential and K+ homeostasis. Unlike other Kir family
members, heteromultimerization of inter-subfamily members
Kir4.1 and Kir5.1 leads to a channel with distinct functional
properties [1–7]. Of particular interest in these newly emerging
properties is the enhanced sensitivity to intracellular pH (pKa
7.45), allowing the heteromeric Kir4.1–Kir5.1 channel to detect
pH changes at physiological levels [3,6–8]. This as well as the
fact that both Kir4.1 and Kir5.1 subunits are expressed in the
kidney, eye and brainstem suggests that the channel may be a⁎ Corresponding author. Department of Biology, Georgia State University, 24
Peachtree Center Avenue, Atlanta, GA 30303, USA. Tel.: +1 404 651 0913;
fax: +1 404 651 2509.
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doi:10.1016/j.bbamem.2007.04.008candidate molecule for the regulation of K+ homeostasis and
central CO2 chemoreception [6,8–10].
The Kir4.1 and Kir5.1 subunits are expressed in the proximal
convoluted tubule, the distal convoluted tubule and the cortical
collecting duct of the kidney [4,5,11]. Immunoprecipitation
studies show that the Kir4.1 and Kir5.1 co-immunoprecipitate
together consistent with the idea that the heteromeric Kir4.1–
Kir5.1 channel plays a role in the absorption of high extra-
cellular K+, a process known as K+ “buffering” [11]. Since K+
secretion in the kidney is tightly linked to systemic pH levels,
the high pH sensitivity of the Kir4.1–Kir5.1 may allow the
channel to control K+ secretion according to systemic acid–base
status. The K+ buffering may be mainly produced by the
Kir4.1–Kir5.1 channel as the homomeric Kir4.1 channel is not
as sensitive to changes in intracellular pH in the physiological
range. Müller cells that are responsible for buffering and
recycling extracellular K+ released by retinal neurons in the eye
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subunits [12]. Whereas Kir4.1 alone exists at the end-feet, both
Kir4.1 and Kir5.1 are detected in the cell body [12]. Genetic
disruption of Kir4.1 causes abnormalities in the Müller cells and
affects K+ buffering in the retina [13]. In the brainstem, mRNAs
for both Kir4.1 and Kir5.1 subunits have been detected together
in neurons in several CO2 chemosensitive areas suggesting a
role of the heteromeric Kir4.1–Kir5.1 channel in central CO2
chemoreception, an important brainstem function for respira-
tory and cardiovascular controls [10].
It is known that the central CO2 chemoreception and K
+
transport in renal epithelium are regulated by neurotransmitters,
hormones and pharmacological agents through specific intra-
cellular signaling systems [14–16]. Therefore, it is possible that
the heteromeric Kir4.1–Kir5.1 channel is regulated by certain
second messenger systems. Such a modulation may enable cells
expressing the Kir4.1–Kir5.1 channel to respond to PCO2 and
pH changes according to systemic needs. One common intra-
cellular signaling system activated by neurotransmitter and
hormone is mediated by protein kinase C (PKC). Indeed, a
number of consensus sequences of potential PKC phosphoryla-
tion sites exist in the Kir4.1 and Kir5.1 subunits. Supporting the
idea of PKC phosphorylation are also previous reports indi-
cating that other Kir channels such as Kir3.1–Kir3.4, Kir2.2,
Kir2.3, and Kir6.2 are modulated by PKC with several phos-
phorylation sites identified in these channel proteins [17–26].
Therefore, we performed experiments to test the possibility that
PKC regulates the Kir4.1–Kir5.1 channel. Our results showed
that the Kir4.1–Kir5.1 channel was strongly inhibited by the
activation of PKC.2. Materials and methods
2.1. Oocytes preparation and injection
Frogs were anesthetized by bathing them in distilled water containing 0.3%
3-aminobenzoic acid ethyl ester. A few lobes of ovaries were removed through a
small abdominal incision (∼5 mm). Then, the surgical incision was closed and
the frogs were allowed to recover from the anesthesia. Xenopus oocytes were
treated with 1 mg/ml of collagenase (Type IA, Sigma Chemicals) in the OR2
solution containing (in mM): NaCl 82, KCl 2, MgCl2 1 and HEPES 5, pH 7.4 for
50 min at room temperature. After five washes (10 min each) of the oocytes with
the OR2 solution, cDNAs (25–50 ng or 5–10 fmol in 50 nl water) were injected
into the oocytes. The oocytes were then incubated at 18 °C in the ND-96
solution containing (in mM): NaCl 96, KCl 2, MgCl2 1, CaCl2 1.8, HEPES 5,
and sodium pyruvate 2.5 with 100 mg/L geneticin and 50 mg/L tetracycline
added (pH 7.4).
2.2. Molecular biology
Rat Kir4.1 cDNA (GenBank #X83585) and rat Kir5.1 cDNA (GenBank
#X83581) are gifts from Dr. John Adelman (Oregon Health & Science
University, Portland, OR). These cDNAs were subcloned into the eukaryotic
expression vector pcDNA3.1 (Invitrogen, Carlsbad, CA) and used for Xenopus
oocyte expression without cRNA synthesis. For co-expression of Kir4.1 and
Kir5.1, a tandem dimer of these two cDNAs was constructed using the
overlapping extension technique, in which full length Kir4.1 and Kir5.1
sequences were obtained using Pfu DNA polymerase (Stratagene, La Jolla, CA)
chain reaction (PCR). The PCR products were joined to each other at the 3′ end
of Kir4.1 and 5′ end of Kir5.1. Correct constructions were confirmed with DNA
sequencing. Site-specific mutations were made using a site-directed mutagenesiskit (Stratagene, La Jolla, CA). Correct constructions and mutations were
confirmed with DNA sequencing. Dynamin II (aa) wild-type and Dynamin II
(aa) K44A are gifts from Dr. Mark McNiven at the Mayo Clinic. These two
cDNAs were subcloned into the eukaryotic expression vector pEGFP-N1
creating an N-terminal GFP-Dynamin fusion and used directly for expression
in Xenopus oocytes.
2.3. Expression and purification of MBP and C-terminal-MBP fusion
proteins
Themembrane and C-terminal cytoplasmic junction for the Kir4.1 (GenBank
#X83585) and Kir5.1 (GenBank #X83581) was determined by ScanProsite. The
C-terminal fragments were amplified by PCR and inserted into the pMALc2x
vector (New England Biolabs) using EcoRI and XbaI. The PCR fragments
contained these restriction enzyme sites as well as a stop codon to terminate
transcription after the C-terminus. To express the maltose binding protein (MBP)
alone a stop codon was introduced to prevent expression of part of the LacZ gene
present in the pMALc2x vector. Correct constructions were confirmedwith DNA
sequencing.
Expression and purification of the fusion proteins were carried out in
Escherichia coli BL21 competent cells. The cells were grown overnight at
37 °C. The next morning the cultures were diluted in LB broth medium and
grown to an A600∼1 at 37 °C. Protein induction was achieved by the addition of
1 mM isopropylthiogalactoside (IPTG) to the cultures which were then
incubated at 25 °C for 2 h. The cells were harvested by centrifugation (4000×g,
15 min, 4 °C). The bacterial pellet was washed with STE (150 mM NaCl;
10 mM Tris, pH 8.0; 1 mM EDTA) plus protease inhibitors (EDTA-free) (Roche
Molecular Biochemicals) once and then resuspended in the same buffer. The cell
membranes were lysed by the addition of lysozyme (100 μg/ml) added
immediately following resuspension. The samples were incubated on ice for
15 min. Dithiothreitol (DTT) (5 mM) was added to the samples and the cell
membranes were further lysed by sonication (4×20 s) followed by centrifuga-
tion (4000×g, 15 min, 4 °C). The resulting supernatant was collected and Triton
X-100 was added to a final concentration of 1%. The supernatant was then
loaded onto amylose resin (New England Biolabs) pre-equilibrated with protein
elution buffer (PEB) (50 mM Tris, pH 8.0; 1 mM EDTA) and incubated on ice
for 45 min. The amylose resin was centrifuged and the supernatant was
discarded. The resin was washed 7 times with 2 volumes of PEB. Elution of the
maltose binding protein (MBP) and MBP fusion proteins was achieved by
incubating the amylose resin with 1 volume of PEB containing 10 mM maltose.
All fractions containing the fusion proteins were pooled and concentrated using
centricon YM-10 centrifugal units (Millipore, Bedford, MA). Protein purity was
determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) (10%) and subsequent Coomassie blue staining. The protein
concentration was determined using a UV spectrophotometer at A280.
2.4. In vitro kinase assay
One μg of purified proteins (Kir4.1-C-terminus-MBP, Kir5.1-C-terminus-
MBP, MBP, Histone III-S) was added to a reaction mixture consisting of the
catalytically active PKC subunit (20 ng) (BioMol, Plymouth Meeting, PA)
10 μCi of 32P-γ-ATP (Perkin Elmer, Waltham, MA), Magnesium/ATP cocktail
(75 mMMgCl2 and 500 μM ATP in 20 mMMOPS, pH 7.2, 25 mM β-glycerol
phosphate, 5 mM EGTA, 1 mM sodium orthovanadate and 1 mM dithiothreitol)
and 5× reaction buffer (containing: 125 mM Tris–HCl, pH 7.5 and 0.1 mM
EGTA) in a total volume of 25 μl. The samples were incubated at 30 °C for 1 h
and 5× loading buffer was added to stop the reaction. The samples were then
analyzed by running a symmetric 10% SDS-PAGE gel. The gel was cut down
the middle and one half was stained with Coomassie brilliant blue solution and
destained and the other half was dried and subjected to autoradiography. The
autoradiograph was taken using the Fujifilm BAS 2500 phosphor imager and
analyzed with the Multigauge software.
2.5. Electrophysiology
Whole-cell currents were studied on oocytes 2–4 days post cDNA injection.
Two-electrode voltage clamp was performed using an amplifier (Geneclamp
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The extracellular solution contained (in mM): KCl 90, MgCl2 3, and HEPES 5
(pH 7.4). The recording pipettes were filled with 3 M KCl. Cells were impaled
with these electrodes. The potential leakage of KCl from the recording
electrodes was not corrected because of the large volume of oocytes. One of the
electrodes (1.0–2.0 Ω) served as the voltage recording which was connected to
the HS-2 x1L headstage (input resistance=1011 Ω) and the other (0.3–0.6 MΩ)
was used for current recording connected to the HS-2 x10MG headstage
(maximum current=130 μA). Oocytes were accepted for further study if they
did not show leakage in membrane currents. Current records were low-pass
filtered (Bessel, 4-pole filter, 3 dB at 1 kHz), digitized at 5 kHz (12-bit
resolution) and stored on a computer disk for later analysis.
Single-channel Kir4.1–Kir5.1 currents were studied in cell-attached patches
using an Axo-patch 200B amplifier (Axon Instruments). The bath solution
contained (in mM): KCl 40, potassium gluconate 75, potassium fluoride 5,Fig. 1. The Kir4.1–Kir5.1 channel but not homomeric Kir4.1 is sensitive to PMA. (A
3 days post-injection of the Kir4.1–Kir5.1 dimer cDNA. With 90 mM K+ in the extra
potential (Vm) was held at 0 mV. A series of command pulse potentials from −160 mV
negative membrane potentials, there was slow activation of the currents. Exposure to
currents by 40%. (B) The same experiment was carried out with the homomeric Kir4
and peak PMA affected currents were scaled to the same magnitude at −160 mV,
superimposed, suggesting that the effects were voltage-independent. (E) The time p
PMAwas present in the bath solution, and reached maximum inhibition in ∼35 misodium vanadate 0.1, potassium pyrophosphate 10, ethylene glycol-bis-β-
aminoethylether-N,N,N′,N′-tetraacetic acid (EGTA) 1, adenosine diphosphate
(ADP) 0.2, piperazine-N,N′-bis-2-ethanesulfonic acid (PIPES) 10, glucose 10
and spermine 0.1 (FVPP solution, pH 7.4). The pipette was filled with the same
FVPP solution used in the bath or a solution containing (mM): KCl 40,
potassium gluconate 110, ADP 0.2, EGTA 1, HEPES 10, glucose 10 and MgCl2
2 (pH 7.4). The pipette tip was∼2 μm for cell-attached patch. The oocytes were
prepared for patch clamp recordings by mechanically removing the vitelline
membranes after being exposed to a hypertonic solution (400 mosm) for 10 min.
The stripped oocytes were placed in a petri dish containing the regular bath
solution (see above). The open-state probability (NPo) was calculated by
counting all active channels from a given patch.
Human embryonic kidney cells (HEK293, CRL-1573, Batch #2187595,
ATCC, Rockville, MD) were chosen to express the Kir4.1–Kir5.1 channel. The
HEK293 Cells were cultured as a monolayer in the DMEM-F12 medium with) Using TEVC whole-cell Kir4.1–Kir5.1 currents were recorded from an oocyte
cellular solution inward rectifying currents were recorded at baseline. Membrane
to 140 mV with a 20-mV increment was applied to the cell. Note that in highly
15 nM PMA (a specific and potent PKC activator) inhibited the Kir4.1–Kir5.1
.1. Exposure to 15 nM PMA failed to inhibit this channel. (C, D) When baseline
the I/V relationship of the currents recorded under these two conditions were
rofile showed that the Kir4.1–Kir5.1 current amplitude decreased rapidly when
n. The Kir4.1 currents remained constant for 30 min during exposure to PMA.
Fig. 2. Concentration-dependent response of PMA. (A) The effect of PMA on
the Kir4.1–Kir5.1 channel was clearly concentration-dependent. The Kir4.1–
Kir5.1 channel was inhibited by very low concentrations of PMA. Exposure to 5
nM PMA suppressed Kir4.1–Kir5.1 channels by 16.9±3.8% (n=5). 1 μMPMA
maximally inhibited the Kir4.1–Kir5.1 currents by 93.3±1.4% (n=4). n≥4 for
each concentration tested. (B) The concentration-dependent response fits a
sigmoid curve. This curve was used to more accurately obtain the IC50
concentration which was 15 nM PMA.
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with 5% atmospheric CO2, the cells were split twice weekly. The HEK293 cells
were transfected using Lipofectamine2000 (Invitrogen, Carlsbad, CA) with
3.5 μg Kir4.1–Kir5.1 dimer cDNA. To facilitate the identification of positively
transfected cells, 0.5 μg green fluorescent protein (GFP) cDNA (pEGFP-N2,
Clontech, Palo Alto, CA) was added to the cDNA mixture. Cells were
disassociated from the monolayer using 0.25% trypsin ∼24 h post-transfection.
A few drops of the cell suspension were added on to 5×5 mm cover slips in
a 35 mm petri dish. The cells were then incubated at 37 °C for an additional
24–48 h before further experiments.
Single-electrode whole-cell voltage-clamp was performed on HEK293
cells at room temperature as described previously [27–29]. In brief, fire-
polished patch pipettes were made from 1.2 mm borosilicate capillary glass
(Sutter Instruments, Novato, CA). Tight seals (N1 GΩ before breaking into the
whole-cell mode) were obtained with the transfected cells. The patch
electrodes had an open tip resistance of 0.5–1.0 MΩ. The series resistance
during recording varied from 5 to 10 MΩ and was not compensated.
Recordings were terminated whenever significant increase (N20%) in series
resistance occurred. Current records were low-pass filtered (2 kHz, Bessel,
4-pole filter, −3 dB), digitized (20 kHz, 16-bit resolution), and stored on
computer disk for later analysis using the pCLAMP 9 software (Axon
Instruments Inc, Foster City, CA). Recordings were performed using solutions
containing equal concentrations of K+ applied to the bath and recording pipettes.
This solution contained (in mM): KCl 40, potassium gluconate 75, potassium
fluoride 5, sodium vanadate 0.1, potassium pyrophosphate 10, ethylene glycol-
bis-β-aminoethylether-N,N,N′,N′-tetraacetic acid (EGTA) 1, adenosine dipho-
sphate (ADP) 0.2, piperazine-N,N′-bis-2-ethanesulfonic acid (PIPES) 10,
glucose 10 and spermine 0.1 (FVPP solution, pH 7.4). 100 nM thymeleatoxin
and 15 nM PMA dissolved in DMSO as well as the same concentration of
DMSO alone was applied to the bath solution. PKCi was added to the pipette
solution at a final concentration of 10 μM.
2.6. Immunocytochemistry
Cultured HEK293 cells were transfected with the Kir4.1–Kir5.1 dimer
cDNA together with GFP cDNA as described above. Three days later, the cells
were fixed with 4% paraformaldehyde in phosphate buffered saline (PBS) (0.1
M, pH 7.4) for 30 min. The cells were washed three times with PBS and then
blocked for 30 min in PBS containing 1% bovine serum albumin (BSA), 10%
normal donkey serum (NDS), and 0.3% Triton X-100. The cultures were then
incubated overnight at 4 °C in the primary antibody of goat anti-Kir5.1 (1:200)
(Santa Cruz Biotechnology, Santa Cruz, CA) diluted in antibody dilution
solution (ADS), containing 0.1% gelatin, 0.1% NaN3, and 0.3% Triton X-100
in PBS. The goat anti-Kir5.1 antibody was used to detect antigen of human, rat,
and mouse origin. After washing five times with ADS (5 min each), the
cultured cells were incubated at 25 °C with Alexa Fluor 594 donkey anti-goat
IgG (Molecular Probes, Eugene, OR) diluted to 1:400 in ADS. The fluores-
cence reaction was first visualized using a Zeiss axioscope 200 fluorescence
microscope (Zeiss, Oberkochen, Germany). Subsequently, fluorescence ima-
ging was performed with a confocal microscope (LSM 510) (Zeiss, Jena,
Germany). The confocal images were taken using a 40× oil immersion objective
lens.
2.7. Chemical administration and exposure
4-α-Phorbol 12-myristate 13-acetate (PMA), 4α-phorbol-12,13-didecano-
ate (4α-PDD) and PKC inhibitor peptide 19–31 (PKCi) were purchased from
Calbiochem (La Jolla, CA). 1-Oleoyl-2-acetyl-sn-glycerol (OAG), thymelea-
toxin, chelerythrine chloride and calphostin-C were purchased from Sigma
(St. Louis, MO). Genistein and wortmannin were purchased from Tocris
(Ellisville, MO). PMA, OAG, thymeleatoxin, genistein, wortmannin, cheler-
ythrine, calphostin-C and 4α-PDD were dissolved in dimethylsulfoxide
(DMSO) as stocks and mixed with a recording solution reaching a final con-
centration as indicated in the results. The final DMSO concentration was
≤0.1%. Other chemicals were dissolved in double-distilled water or experi-
mental solutions. Exposures to these chemicals were done after baseline currents
were stabilized.2.8. Data analysis
Data are presented as means±s.e. (standard error). Student t test or single-
factor ANOVA was used to examine differences of chemical effects before
versus during chemical exposures. The differences were considered to be
statistically significant if P≤0.05.3. Results
3.1. Inhibition of the Heteromeric Kir4.1–Kir5.1 Channel by
PMA
In two-electrode voltage clamp, inward rectifying K+
currents were recorded from Xenopus oocytes 2–3 days post
injection of the Kir4.1–Kir5.1 cDNA using a bath solution
containing 90 mM K+. Typical Kir4.1–Kir5.1 currents were
revealed: small outward currents and large inward currents with
slow activation at highly negative membrane potentials (Fig.
1A). Following stabilization of the baseline currents, PMA, a
specific and potent PKC activator, was added to the bath solu-
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Kir4.1–Kir5.1 currents. This inhibition was dose-dependent
(Fig. 2A, B): evident channel inhibition was seen with PMA
concentrations as low as 5 nM; maximum effect occurred with
1 μM PMA at which the Kir4.1–Kir5.1 currents were inhibited
by 93.3±1.4% (n=4); and 15 nM PMA inhibited the Kir4.1–
Kir5.1 currents by 41.4±2.2% (n=13). In comparison, the
homomeric Kir4.1 channel showed no response to 15 nM PMA
(Fig. 1B), and was slightly inhibited (8.4±8.6%, n=5) by
100 nM PMA. Numerous attempts were made to express the
homomeric Kir5.1 channel. Unfortunately, we were unable to
detect inward rectifying K+ currents that were sensitive to
micromolar concentrations of barium in Xenopus oocytes and
HEK293 cells. Therefore, we were unable to determine the
effect of PMA on the Kir5.1 channel.Fig. 3. PKC activation inhibits the Kir4.1–Kir5.1channel. (A) Currents were recorded
inhibited (46.3%) by exposure to 50 μM OAG (another potent activator of PKC).
thymeleatoxin (activator of the conventional PKC isoforms α, β, γ) resulted in a sim
condition as in B. Prior to application of 100 nM thymeleatoxin the cell was pre-incu
1 h. Blocking activation of tyrosine kinases failed to reduce the inhibition by thyme
expressing the homomeric Kir4.1 channel. This channel was barely inhibited by 50 μ
PMA appears to be via activation of PKC as Forskolin (a PKA activator) shows very
PMA) had a significant effect. n≥4 for each experiment.The voltage dependence was analyzed using the current–
voltage (I–V) plot. The currents recorded at −160 mV were
normalized to the same level for both baseline and PMA
treatment. When plotted in the I–V curve, the curve of the PMA
treatment overlapped that obtained from the baseline suggesting
that the inhibition of the Kir4.1–Kir5.1 currents by PMA is
voltage independent (Fig. 1C). The same analysis on the Kir4.1
showed an identical effect (Fig. 1D).
When the time course of the Kir4.1–Kir5.1 channel
inhibition by 15 nM PMA was plotted, the inhibition started
2 min after exposure to PMA and reached the maximum in
∼30 min (Fig. 1E). Thus, all PMA experiments were done with
a PMA exposure of 20–40 min. Higher concentrations of PMA
resulted in a more rapid inhibition of the Kir4.1–Kir5.1 currents
(Online Fig. 3E).from an oocyte in the same condition as in Fig. 1A. These currents were strongly
(B) Exposure of an oocyte expressing the Kir4.1–Kir5.1 channel to 100 nM
ilar inhibition (48.9%). (C) Currents were recorded from an oocyte in the same
bated with 100 μMGenistein (a potent and general tyrosine kinase inhibitor) for
leatoxin. (D, E) The same experiments in A and B were carried out on oocytes
M OAG and 100 nM thymeleatoxin 8.9%, 6.8%, respectively. (F) The effect of
little inhibition. Also, neither DMSO alone nor 4α-PDD (an inactive analog of
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To demonstrate that PKC activation underscores the PMA
inhibition of Kir4.1–Kir5.1, we took advantage of several other
specific kinase activators and inhibitors. Exposure of the
oocytes to the phorbol ester (OAG), another PKC activator,
resulted in a similar inhibition as PMA (Fig. 3A, F).
Thymeleatoxin (100 nM), that selectively activates the conven-
tional PKC isoforms (α, β, & γ), brought about an inhibition of
the Kir4.1–Kir5.1 channel (47.8±2.5%, n=5) to the same
degree as PMA (PN0.05), suggesting that at least one of the
conventional PKC isoforms is involved (Fig. 3B, F). In contrast,
the homomeric Kir4.1 was not inhibited by OAG and
thymeleatoxin, consistent with the results from PMA (Fig.
3D–F). An inactive analogue of PMA (4α-PDD, 15 and 20 nM)
failed to inhibit the Kir4.1–Kir5.1 channel (Fig. 3F; Online Fig.
3B, D, E).
The cAMP dependent protein kinase A (PKA) has been
shown to modulate Kir channels [19,20,26,30]. We therefore
used forskolin that activates the enzyme adenylyl cyclase
leading to increases in the cAMP concentration and activation
of PKA. With 100 μM forskolin, oocytes expressing the
Kir4.1–Kir5.1 channel showed a modest inhibition of theFig. 4. PKC activation inhibits the Kir4.1–Kir5.1channel in HEK293 cells. (A) Whol
Kir5.1 dimer cDNAwith a holding potential at 0 mVand command pulses of −80 mV
with the extracellular solution for a 2- to 5-min period of baseline recording. The
magnification of the current at the time point and shown on the right. (B) In the presen
Kir4.1–Kir5.1 channel. (C) Inhibition of the Kir4.1–Kir5.1 channel was also seen wit
results in inhibition of the Kir4.1–Kir5.1 channel. In each experiment n≥6.currents (10.2±3.3%, n=8; Fig. 3F), suggesting that the PMA-
induced channel inhibition is not a result of PKA activation.
Specific PKC inhibitors were studied, in which oocytes were
pre-incubated in chelerythrine or calphostin-C prior to PMA
application to the recording solution. The pre-incubation of cells
with 3 μM calphostin-C for 2 h resulted in a complete eli-
mination of the PMA-induced inhibition (Fig. 5A, B). A similar
effect was seen with chelerythrine (50 μM for 1 h), though to a
lesser degree (Fig. 5B). Pre-incubation with genistein, a potent
inhibitor of tyrosine kinases did not block the PMA effect (Fig.
3C, F). These results strongly suggest that the PMA inhibition
of the Kir4.1–Kir5.1 channel is mediated by PKC, but neither
by PKA nor by tyrosine kinase activation.
3.3. Inhibition of the Kir4.1–Kir5.1 Channel by PKC activation
in HEK293 cells
The Kir4.1–Kir5.1 channel was transiently expressed in
HEK293 cells. Whole-cell voltage clamp was performed on
GFP-positive cells. Both the bath and pipette solutions con-
tained 145 mMK+. The Kir4.1–Kir5.1 positive transfected cells
showed typical Kir4.1–Kir5.1 currents that were relatively big
at the basal level upon the formation of the whole-cell confi-e-cell currents were recorded from an HEK293 cell transfected with the Kir4.1–
in every 3 s. After the whole-cell configuration was formed, the cell was perfused
currents were inhibited by exposure to 15 nM PMA. The arrow represents the
ce of the PKC inhibitory peptide (10 μMPKCi), 15 nM PMA failed to inhibit the
h exposure to 100 nM thymeleatoxin. (D) Bargraph showing that PKC activation
Table 1
Effect of 15 nM PMA on wild-type Kir4.1, Kir4.1–Kir5.1 and mutant channels
Baseline (μA) PMA (μA) % effect N
Kir4.1–Kir5.1 (Dim) 6.5±0.6 3.8±0.43 −41.4±1.9 13
Kir4.1+Kir5.1 (Co-inj) 8.9±2.1 5.2±1.2 −40.7±1.9 6
Kir4.1 (homomer) 15.3±2.3 15.23±2.2 −0.04±2.2 6
Kir4.1K67M–Kir5.1 20.53±3.0 12.3±2 −41.35±3.23 6
Kir4.1T178A–Kir5.1 3.4±0.7 2.22±0.43 −33.1±2.9 6
Kir4.1S206A–Kir5.1 6.0±1.3 3.8±0.84 −36.7±3.7 13
Kir4.1T214A–Kir5.1 3.3±0.2 2.1±0.2 −37.2±4.6 11
Kir4.1T262A–Kir5.1 16.96±1.5 11.1±1.3 −34.9±3.5 5
Kir4.1T262S–Kir5.1 14.1±0.7 9.7±0.6 −31.4±2.9 5
Kir4.1S263A–Kir5.1 9.7±1.0 6.2±1.0 −36.2±3.9 4
Kir4.1S299A–Kir5.1 8.8±1.6 5.4±1.0 −38.6±2.9 7
Kir4.1S320A–Kir5.1 4.7±0.6 3.0±0.6 −39.0±5.0 7
Kir4.1T346A–Kir5.1 4.8±0.4 2.75±0.48 −44.1±7.1 6
Kir4.1S360A–Kir5.1 4.0±0.4 2.3±0.23 −40.3±5.8 4
Kir4.1S373A–Kir5.1 4.1±0.4 2.46±0.23 −38.1±7.3 7
Kir4.1–Kir5.1T68A 11.9±0.8 8.2±0.5 −30.5±1.5 7
Kir4.1–Kir5.1T174A 3.1±0.3 1.9±0.27 −38.1±4.1 5
Kir4.1–Kir5.1T174D 16.5±3.9 15.38±3.3 −0.9±7.2 8
Kir4.1–Kir5.1T174K 5.1±1.1 2.94±0.61 −40.1±9.6 7
Kir4.1–Kir5.1R178Q 6.2±0.5 3.88±0.54 −37.8±4.0 7
Kir4.1–Kir5.1T181A 3.8±0.3 2.08±0.31 −45.8±4.7 5
Kir4.1–Kir5.1S185A 10.1±0.6 6.28±0.64 −37.8±5.1 4
Kir4.1–Kir5.1T215A 3.6±0.2 2.08±0.17 −40.8±7.2 5
Kir4.1–Kir5.1T232A 4.0±0.5 2.3±0.27 −41.4±5.6 4
Kir4.1–Kir5.1S298A 10.2±0.4 6.12±0.82 −39.4±8.5 4
Kir4.1–Kir5.1T370A 3.6±0.4 2.26±0.25 −36.6±5.2 7
Kir4.1T32A-S299A–Kir5.1 22.5±3.3 14.8±3.17 −36.4±5.8 6
Kir4.1K67M–Kir5.1T68A 8.5±3.3 5.95±2.6 −35.8±5.2 4
Kir4.1T262A–Kir5.1T68A 11.04±0.6 7.1±0.27 −35.3±3.4 5
Kir4.1–Kir5.1V211L 4.5±0.6 2.6±0.4 −41.2±5.7 10
Kir4.1L208V 10.4±2.0 9.45±1.9 −10.1±4.7 7
Kir4.1L208I n.f. n.f.
Kir4.1L208V–Kir5.1 7.8±1.46 4.77±0.8 −37.8±2.9 6
Kir4.1L208I–Kir5.1 n.f. n.f.
Abbreviations: N, number of observation; n.f., nonfunctional.
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level for more than 5 min. The cells were held at a membrane
potential of 0 mV. Command pulses of −80 mV were applied to
the cell every 3 s and the Kir4.1–Kir5.1 currents were recorded.
Application of 15 nM PMA strongly inhibited the Kir4.1–
Kir5.1 channel by 39.3±2.1% (n=10) (Fig. 4A, D). The
inhibition by 15 nM PMAwas greatly diminished [1.40±2.6%
(n=6)] in the presence of the PKC inhibitor peptide (10 μM
PKCi) that was added to the pipette solution (Fig. 4B, D).
100 nM thymeleatoxin similar to 15 nM PMA also inhibited the
Kir4.1–Kir5.1 channel [44.7±2.6% (n=10)] expressed in
HEK293 cells. However, an inactive analogue of PMA (4α-
PDD) only inhibited the Kir4.1–Kir5.1 currents in HEK293 cell
by 10.7±2.7% (n=9) (Fig. 4D). Taken together, these results
suggest that the Kir4.1–Kir5.1 channel is inhibited by PKC
activation in HEK293 cells in a similar manner as in Xenopus
oocytes.
3.4. Independence of PIP2
A number of Kir channels are regulated by membrane lipids
including phosphatidylinositol bisphosphate (PIP2). The pre-
sence of this phospholipid has been shown to increase Kir
channel activity, and consequently depletion of PIP2 leads to
channel inhibition. To test the possibility that the PMA-induced
Kir4.1–Kir5.1 channel inhibition is related to PIP2 depletion,
we mutated the potential PIP2 binding sites in the channel to
increase or decrease the channel affinity for the phospholipid
based on a sequence alignment with other Kir channels
[21,31,32]. One mutant R178Q, that has previously been
reported to increase PIP2 binding affinity [7], was created in the
Kir5.1 and expressed with wild-type Kir4.1. This mutant
channel showed a similar PMA sensitivity as the wild-type
(Table 1). Another mutant Kir4.1–Kir5.1V211L, that has also
been shown to increase the PIP2 sensitivity, did not affect the
channel inhibition by 15 nM PMA (41.2±5.7%, n=10) (Fig.
5C). A converse mutation, exchanging these residues at a
different site on the Kir4.1 (Kir4.1L208V) had no effect.
To further assess the effect of PIP2 depletion in the channel
inhibition, wortmannin that inhibits the phosphoinositide
kinase-3 (PI3K) and thus the resynthesis of PIP2 from PIP3
was used to treat the oocytes prior to PMA exposure. Following
incubation of oocytes with 10 μMwortmannin, PMA continued
to inhibit the Kir4.1–Kir5.1 channel by 41.4±8.8% (n=5) (Fig.
3F). Taken together these results suggest that PIP2 depletion
does not seem to underlie the PMA-induced Kir4.1–Kir5.1
channel inhibition.
3.5. Single-channel properties affected
The effect of PMA on the single-channel biophysical pro-
perties was studied in Xenopus oocytes using cell-attached
patches with 145 mMK+ applied to the extracellular solution at a
membrane potential of −80 mV. Only patches containing ≤4
active channels were considered in the experiment (Fig. 6).
Inward rectifying currents with single-channel conductance of
∼40 pS were recorded from oocytes that were injected with theKir4.1–Kir5.1 cDNA 2–3 days prior to recordings. These
currents were inhibited with an exposure of the cells to 15 nM
PMA (Fig. 6A). The current inhibition was mainly produced by a
suppression of the channel open-state probability (Popen), while
the single-channel conductance was barely effected (Fig. 6).
3.6. Lack of evidence for endocytosis
Several recent studies indicate that protein kinase activation
can lead to endocytosis and thus the suppression of surface Kir
channel activity [33–37]. To evaluate the role of endocytosis in
the inhibition of the Kir4.1–Kir5.1 channel by PKC activation,
we carried out experiments with dynamin II and its dominant
negative mutant where lysine at position 44 is mutated to
alanine (K44A). We reasoned that co-expression of this
dominant-negative dynamin II may abolish the effect of PKC
if the Kir4.1–Kir5.1 channel inhibition by PKC results in
dynamin dependent endocytosis. The Kir4.1–Kir5.1 channel
was co-expressed with the wild-type dynamin II as well as the
dynamin II K44A mutant. Exposure to 15 nM PMA led to
inhibition of the currents by 53.2±4.4% (n=4) in the cells
expressing the wild-type dynamin II (Fig. 7A, D) and by 49.5±
Fig. 5. PKC is necessary for inhibition of Kir4.1–Kir5.1 by PMA. (A) Using TEVC whole-cell Kir4.1–Kir5.1 currents were recorded from an oocyte 3 days post-
injection of the Kir4.1–Kir5.1 dimer cDNA. With 90 mM K+ in the extracellular solution inward rectifying currents were recorded at baseline. Membrane potential
(Vm) was held at 0 mV. A series of command pulse potentials from −160 mV to 140 mV with a 20-mV increment was applied to the cell. Before exposure to 15 nM
PMA the oocyte was pre-incubated with 3 μM Calphostin-C (a potent and specific inhibitor of PKC) for 2 h. Inhibition of PKC drastically attenuated the effect of
PMA. PMA exposure after incubation with calphostin-C slightly activated the Kir4.1–Kir5.1 currents by 9.8%. (B) Pre-incubation of oocytes with specific PKC
inhibitors (50 μM chelerythrine or 3 μM calphostin-C) strongly attenuated the effect of 15 nM PMA (n≥4). (C) Whole-cell currents were recorded from an oocyte
3 days post injection of the Kir4.1–Kir5.1V211L mutant channel recorded under the same condition as in A. This mutant is suggested to have increased PIP2 affinity.
Exposure of the oocytes to 15 nM PMA inhibited the Kir4.1–Kir5.1V211L currents by 57.6%. (D) The converse mutant was created on the Kir4.1 channel
(Kir4.1L208V) and tested in an oocyte under the same experimental conditions as for Fig. 4C. Similarly as for the wild-type channel this mutant failed to be inhibited
by 15 nM PMA.
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(Fig. 7B, D).
Another mechanism of endocytosis involves clathrin-coated
pits. Proteins that undergo clathrin-dependent endocytosis
contain an internalization recognition motif in at least one of
the intracellular domains, usually in the C-terminal. This motif
[(Y/F)(D/E)NPXY] shares high homology in many proteins. A
primary scan of the Kir4.1 amino acid sequence failed to show
any similar recognition motif. However, a scan of the Kir5.1 led
to the identification of such a motif. The second and third amino
acids of the motif have been found to be critical for endocytosis
of Kir1.1 [37]. Therefore, we mutated these residues in Kir5.1.
Consistent with the dynamin experiment we found that the
Kir4.1–Kir5.1E260A/S261A mutant remained highly sensitive
to PMA (Fig. 7C, D).
To further assess the possibility of channel endocytosis,
whole cell currents were recorded from HEK293 cells before
and during treatment with thymeleatoxin. The whole cell
capacitance (CAP) and series resistance (SR) were measured. If
the Kir4.1–Kir5.1 channel inhibition by PKC activation was a
result of endocytosis, the whole cell capacitance would decreasefollowing application of thymeleatoxin to the bath solution. The
percent change in the whole cell capacitance of HEK293 cells
expressing the Kir4.1–Kir5.1 channel exposed to 100 nM
thymeleatoxin for 15 min was 5.9±8.2% (n=4). This change in
capacitance did not significantly differ from that of cells
exposed to DMSO only (3.1±9.9%, n=4) (Online Fig. 1). The
series resistance did not show a significant difference between
cells exposed to DMSO versus cells exposed to 100 nM
thymeleatoxin (Online Fig. 1).
We also performed immunocytochemistry to demonstrate
membrane expression of the Kir4.1–Kir5.1 channel. Both the
Kir4.1 and Kir5.1 antibodies are commercially available. By
taking advantage of these antibodies and using immunocyto-
chemistry we decided to look at membrane expression of the
Kir4.1–Kir5.1 channel before and after exposure to PMA.
HEK293 cells were transfected with the Kir4.1–Kir5.1 dimer.
Immunocytochemistry was performed as described in the
Materials and methods. Prior to PMA exposure the channel
showed membrane surface expression (Online Fig. 2A1–A3).
After exposure to 15 nM PMA for 25 min the membrane
expression was retained (Online Fig. 2B1–B3). Taken together
Fig. 6. Effects of PMA on the single channel properties of the Kir4.1–Kir5.1. (A) Single Kir4.1–Kir5.1 currents were recorded from an oocyte in a cell-attached patch
configuration with 145 mM K+ in the patch pipette. At Vm of −80 mV, two active channels are seen at pH 7.4. Following stabilization, exposure to 15 nM PMA
reduced the channel activity by a decrease in the NPo. Labels on the left: c, closure; 1, the first opening; 2, the second opening; etc. (B, C) Bargraph showing that 15 nM
PMA drastically reduced the Po, but did not affect the single-channel conductance (n≥6).
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does not seem to be a result of endocytosis.
3.7. Phosphorylation sites
To identify the PKC phosphorylation site, a sequence
alignment of amino acids was made for both the Kir4.1 and
Kir5.1 channels. Numerous putative PKC phosphorylation sites
were found in Kir4.1 and Kir5.1, according to the consensus
sequence, i.e., R(K)–X0–2–T/S–X0–2–R(K). Four different
phosphorylation prediction programs were also used to predict
potential PKC phosphorylation sites (NetPhos, Scansite,
ScanProsite, Phosphobase). We performed systematic screening
of these predicted sites according to the prediction programs in
both Kir4.1 and Kir5.1 by single mutation of the serines or
threonines to an alanine residue. The effect of PMA on these
mutants was tested subsequently in Xenopus oocytes. The
mutant channels were grouped: the first group of mutants
consisted of the potential phosphorylation sites that were
predicted using all prediction programs and had the highest
score for potential phosphorylation by PKC; the second group
consisted of those residues that had a lower phosphorylation
prediction score; and the third group was residues not predicted
by the phosphorylation prediction programs, but was found in a
sequence similar to the consensus sequence for PKC. We tested
30 mutant channels with a single mutation representing eachgroup and 9 channels with double mutations. All single mutants
tested except for Kir4.1–Kir5.1T174D remained highly sensi-
tive to PMA (Online-Fig. 4A, B, Table 1). Further analysis of
the Kir4.1–Kir5.1T174 position suggests that it is involved in
another channel function as mutants carrying an alanine or
lysine at this position remained sensitive to PMA (Online-Fig.
4G, Table 1). Also the Kir4.1–Kir5.1T174D mutant also failed
to respond to 15% CO2. Single channel analysis showed that the
T174D mutant has an increased Popen (Online-Fig. 4D). Taken
together we concluded that the T174 position is not a PKC
phosphorylation site. The double mutants were created by
comparing the PMA effect of the single mutants and selecting
those that had a slightly lower PMA sensitivity. When tested,
the double mutants also showed a PMA sensitivity similar to the
wild-type. Therefore, the PKC phosphorylation sites remain to
be demonstrated.
3.8. Direct phosphorylation of Kir4.1 and Kir5.1
The failure to demonstrate PKC phosphorylation sites raises
a question as to whether the channel proteins are indeed
phosphorylated by PKC. Thus, we performed in vitro
phosphorylation experiments. Since most of the predicted
PKC sites are located in the C-terminus of Kir4.1 and Kir5.1,
MBP fusion peptides with the Kir4.1-C-terminus and Kir5.1C-
terminus were produced as described in the Materials and
Fig. 7. PKC activation inhibits Kir4.1–Kir5.1 currents independent of endocytosis. (A)Whole-cell currents were recorded from an oocyte 3 days following injection of
the Kir4.1–Kir5.1+ dynamin II cDNAs (co-injection) under the same conditions as described for Fig. 1A. PMA exposure inhibited the Kir4.1–Kir5.1+ dynamin II
currents by 48%. (B) Whole-cell Kir4.1–Kir5.1 currents were recorded from an oocyte 3 days following injection of the Kir4.1–Kir5.1+ dynamin II K44A mutant
cDNAs (co-injection) using TEVC. Exposure to 15 nM PMA also inhibited the Kir4.1–Kir5.1+ dynamin II K44A (−59%). (C) Whole-cell currents were recorded
from an oocyte 3 days following injection of the Kir4.1–Kir5.1E260A/S261Amutant channel. This mutant has lost the recognition site for CCVendocytosis. Exposure
of the oocyte to 15 nM PMA inhibited the Kir4.1–Kir5.1E260A/S261A currents by 42%. (D) Bargraph summarizing panels A, B, and C. Note that the Dynamin K44A
mutant and the Kir4.1–Kir5.1E260A/S261A mutant showed no significant difference to the Kir4.1–Kir5.1 in respect to inhibition by PMA in the bargraph. n≥4 for
each experiment.
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were incubated with 32P-γ-ATP in the presence of the
catalytically active subunit of PKC (20 ng). Such a treatment
led to positive phosphorylation of these peptides suggesting that
both Kir4.1 and Kir5.1 are directly phosphorylated by PKC
(Fig. 8).Fig. 8. Phosphorylation of MBP fusion proteins. (A) 10% SDS-PAGE gel
showing the presence of the Kir4.1-C-terminus-MBP (∼65 kDa) (lane 2),
Kir5.1-C-terminus-MBP (∼70 kDa) (Lane 3), MBP alone (∼42 kDa) (Lane 4)
and Histone III-S (Lane 5). The size is indicated by the ladder (Lane 1)
(precision plus protein standards) (Biorad). (B) Autoradiograph after 12 h
showing phosphorylation of Kir4.1-C-terminus-MBP, Kir5.1-C-terminus-MBP,
MBP, and Histone III-S. The proteins were incubated in the presence of 32P-γ-
ATP and the catalytically active PKC subunit.4. Discussion
Protein phosphorylation is an important process in regulating
cellular functions. Several inward rectifying K+ channels have
been shown to be regulated by protein kinase phosphorylation
[17–26,30,38]. For example, the heteromeric GIRK1-GIRK4
channel has previously been shown to be phosphorylated by
protein kinase C at specific serine residues in the channel
protein affecting channel gating [21]. This phosphorylation
underscored the effect of substance-P on this channel allowing
the channel to partake in the cellular response to this
neurotransmitter.
In the present study we have presented evidence for the
inhibition of the heteromeric Kir4.1–Kir5.1 channel by PKC.
The Kir4.1–Kir5.1 channel is inhibited by nanomolar concen-
trations of PMA in a dose-dependent manner. Several
experiments show that the effect of PMA is specific. Pre-
incubation of the oocytes with specific PKC blockers (chele-
rythrine and calphostin-C) abolishes the PMA effect. Exposure
of oocytes to 4α-PDD (an analogue of PMA incapable of
activating PKC) fails to inhibit the Kir4.1–Kir5.1 channel. On
the other hand, two other PKC activators (OAG & thymelea-
toxin) strongly inhibit the channel. The biophysical mechanism
for the inhibition of the Kir4.1–Kir5.1 channel by PKC appears
to be mediated by reducing the channel open state probability
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Kir5.1 channel inhibition does not seem to be produced by PKA
and tyrosine kinase as forskolin and genistein have rather small
effects.
The PKC induced inhibition of the Kir4.1–Kir5.1 channel is
independent of PIP2 and does not seem to be mediated by
endocytosis. Since PIP2 has been shown to regulate many Kir
channels it is possible that the PKC induced inhibition of the
Kir4.1–Kir5.1 was a result of PIP2 depletion. The above
experiments show that PMA inhibits the Kir4.1–Kir5.1 channel
independent of PIP2 depletion. Similarly, mutant channels with
increased PIP2 binding remains to be inhibited by PMA
exposure to the same degree as the wild-type. Also, pre-
incubation of oocytes with worthmannin (a PI3K inhibitor that
reduces PIP2) fails to abolish the PMA induced inhibition of the
channel, suggesting that the channel inhibition is not a result of
PIP2 depletion. Immunocytochemistry experiments demonstrat-
ing surface expression in addition to experiments using a
defective dynamin II mutant show that the effect of PMA is not
a result of endocytosis. Although there may be other
mechanisms involved, these results suggest that activation of
PKC inhibits the Kir4.1–Kir5.1 channel by changing the
channel gating mechanism (Fig. 9).
Our biochemical experiments suggest a direct phosphoryla-
tion of the channel protein as both C-termini of Kir4.1 and
Kir5.1 can be phosphorylated by PKC (Fig. 9). To find the PKC
phosphorylation sites, we screened more than 30 serine/
threonine residues (some identified as phosphorylation sitesFig. 9. Schematic for the inhibition of Kir4.1–Kir5.1 channels by PKC. The
inhibition of the Kir4.1–Kir5.1 channel is through the activation of PKC by way
of DAG activation. The channel appears to be inhibited by PKC directly
(phosphorylation) and not by a reduction of PIP2.by prediction software programs) by mutation to a non-
phosphorylatable amino acid. None of the single mutations led
to identification of the phosphorylation site, as all single mutants
tested except for Kir5.1T174D remained highly sensitive to
PMA. The Kir5.1T174 is not a PKC phosphorylation site either,
as the Kir5.1T174A and Kir5.1T174K mutants are strongly
inhibited by PMA. The effect of the T174D mutation suggests
that this residue or its surrounding area may play a role in the
channel gating mechanism and/or regulation by other intracel-
lular factors. This mutant channel lost the sensitivity to both CO2
and PKC. Since this area contains several charged residues it is
possible that a change in electrostatic charge in this area by the
T174D affects the process of channel gating. Several double
mutations based on single sites shown by phosphorylation
prediction programs were also tested. None of these double
mutations affects the PMA sensitivity. Therefore, we believe
that the heteromeric combination of the Kir4.1–Kir5.1 channel
may introduce multiple phosphorylation sites whose phosphor-
ylation collectively may result in a change in channel activity.
Removal of one or two of the phosphorylation sites may not be
adequate to abolish the channel inhibition by PKC. This is
further supported by the in vitro phosphorylation experiments
that shows both Kir4.1 and Kir5.1 C-termini are directly
phosphorylated by PKC. The Kir4.1 channel can express as a
homomeric channel in several tissues [12,39,40,41,42,43].
However, this channel has low pH sensitivity [6,44,45] and is
insensitive to phosphorylation by PKC according to our current
studies. The Kir5.1 channel on the other hand is believed to only
function in nature through heteromultimerization with either
Kir4.1 or Kir4.2. Indeed, there is a study showing the existence
of mRNA for both Kir4.1 and Kir5.1 channels in neurons of the
brainstem suggesting that the heteromeric combination exists in
these neurons [10]. In addition to brainstem expression, the
Kir4.1–Kir5.1 channel has CO2/pH sensitivity in the physiolo-
gical range [6,8,9]. This channel directly couples the CO2/pH
sensitivity to membrane excitability [8]. All of these properties
of the Kir4.1–Kir5.1 allows for its consideration as a CO2
central chemoreceptor molecule in the brainstem.
Brainstem neurons in addition to being regulated by pH are
modulated by numerous hormones and neurotransmitters. This
receptor ligand interaction is often used to identify certain
neurons in the brainstem. Although receptor activation leads to
multiple second messenger cascades, a common receptor
activated cascade appears to be activation of phospholipase-C
β that cleaves PIP2 into IP3 and DAG. The PIP2 derivative
DAG activates PKC and IP3 increases intracellular calcium
which is also necessary for PKC activation. Therefore, it would
be very interesting to determine if the Kir4.1–Kir5.1 channel
can be modulated by neurotransmitters and hormones through
activation of GPCRs that are expressed in neurons of the
brainstem and whether activation of PKC is involved in this
modulation. For example, neurons of the locus coeruleus
(expressing the NK1R) that are regulated by the neurokinin
substance-P have been shown to contain mRNA for both Kir4.1
and Kir5.1 [10]. Therefore, further studies are needed to
understand the modulation of the Kir4.1–Kir5.1 channel by
G-protein coupled receptors that lead to PKC activation.
2041A. Rojas et al. / Biochimica et Biophysica Acta 1768 (2007) 2030–2042Acknowledgements
Special thanks to Ms. Dyanna Fountain and Ms. Carmen
Adams for their technical assistance. We also thank Ms. Heena
Tapankumar Dey and Mr. Malcolm E. Johns for their assistance
with the in vitro phosphorylation experiments. We are grateful
to Dr. John Adelman for the gifts of Kir4.1 and Kir5.1. We are
also grateful to Dr. Mark McNiven for the gift of Dynamin II
(aa) wild-type and K44A mutant. This work is supported by the
NIH (HL067890).Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.bbamem.2007.04.008.References
[1] M. Casamassima, M.C. D'Adamo, M. Pessia, S.J. Tucker, Identification of
a heteromeric interaction that influences the rectification, gating, and pH
sensitivity of Kir4.1/Kir5.1 potassium channels, J. Biol. Chem. 278 (2003)
43533–43540.
[2] A.A. Konstas, C. Korbmacher, S.J. Tucker, Identification of domains that
control the heteromeric assembly of Kir5.1/Kir4.0 potassium channels,
Am. J. Physiol., Cell Physiol. 284 (2003) C910–C917.
[3] M. Pessia, P. Imbrici, M.C. D'Adamo, L. Salvatore, S.J. Tucker,
Differential pH sensitivity of Kir4.1 and Kir4.2 potassium channels and
their modulation by heteropolymerisation with Kir5.1, J. Physiol. 532
(2001) 359–367.
[4] M. Tanemoto, N. Kittaka, A. Inanobe, Y. Kurachi, In vivo formation of a
proton-sensitive K+ channel by heteromeric subunit assembly of Kir5.1
with Kir4.1, J. Physiol. 525 (Pt 3) (2000) 587–592.
[5] S.J. Tucker, P. Imbrici, L. Salvatore, M.C. D'Adamo, M. Pessia, pH
dependence of the inwardly rectifying potassium channel, Kir5.1, and
localization in renal tubular epithelia, J. Biol.Chem. 275 (2000)
16404–16407.
[6] H. Xu, N. Cui, Z. Yang, Z. Qu, C. Jiang, Modulation of kir4.1 and kir5.1 by
hypercapnia and intracellular acidosis, J. Physiol. 524 (Pt. 3) (2000)
725–735.
[7] Z. Yang, H. Xu, N. Cui, Z. Qu, S. Chanchevalap, W. Shen, C. Jiang,
Biophysical and molecular mechanisms underlying the modulation of
heteromeric Kir4.1–Kir5.1 channels by CO2 and pH, J. Gen. Physiol. 116
(2000) 33–45.
[8] N. Cui, L.R. Giwa, H. Xu, A. Rojas, L. Abdulkadir, C. Jiang, Modulation
of the heteromeric Kir4.1–Kir5.1 channels by P(CO(2)) at physiological
levels, J. Cell Physiol. 189 (2001) 229–236.
[9] C. Jiang, H. Xu, N. Cui, J. Wu, An alternative approach to the
identification of respiratory central chemoreceptors in the brainstem,
Respir. Physiol. 129 (2001) 141–157.
[10] J. Wu, H. Xu, W. Shen, C. Jiang, Expression and coexpression of CO2-
sensitive Kir channels in brainstem neurons of rats, J. Membr. Biol. 197
(2004) 179–191.
[11] M. Tanemoto, T. Abe, T. Onogawa, S. Ito, PDZ binding motif-dependent
localization of K+channel on the basolateral side in distal tubules, Am. J.
Physiol., Renal Physiol. 287 (2004) F1148–F1153.
[12] M. Ishii, A. Fujita, K. Iwai, S. Kusaka, K. Higashi, A. Inanobe, H. Hibino,
Y. Kurachi, Differential expression and distribution of Kir5.1 and Kir4.1
inwardly rectifying K+ channels in retina, Am. J. Physiol., Cell Physiol.
285 (2003) C260–C267.
[13] P. Kofuji, P. Ceelen, K.R. Zahs, L.W. Surbeck, H.A. Lester, E.A. Newman,
Genetic inactivation of an inwardly rectifying potassium channel (Kir4.1
subunit) in mice: phenotypic impact in retina, J. Neurosci. 20 (2000)
5733–5740.[14] J.L. Feldman, G.S. Mitchell, E.E. Nattie, Breathing: rhythmicity, plasticity,
chemosensitivity, Annu. Rev. Neurosci. 26 (2003) 239–266.
[15] W.J. Germann, C.L. Stanfield, The urinary system; fluid and electrolyte
balance, Principles of Human Physiology, Benjamin Cummings, San
Francisco, 2005, pp. 618–631.
[16] G.B. Richerson, Serotonergic neurons as carbon dioxide sensors that
maintain pH homeostasis, Nat. Rev., Neurosci. 5 (2004) 449–461.
[17] B. Fakler, U. Brandle, E. Glowatzki, H.P. Zenner, J.P. Ruppersberg, Kir2.1
inward rectifier K+ channels are regulated independently by protein
kinases and ATP hydrolysis, Neuron 13 (1994) 1413–1420.
[18] P. Henry, W.L. Pearson, C.G. Nichols, Protein kinase C inhibition of
cloned inward rectifier (HRK1/KIR2.3) K+ channels expressed in Xenopus
oocytes, J. Physiol. 495 (Pt 3) (1996) 681–688.
[19] P.E. Light, C. Bladen, R.J. Winkfein, M.P. Walsh, R.J. French, Molecular
basis of protein kinase C-induced activation of ATP-sensitive potassium
channels, Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 9058–9063.
[20] Y.F. Lin, Y.N. Jan, L.Y. Jan, Regulation of ATP-sensitive potassium
channel function by protein kinase A-mediated phosphorylation in
transfected HEK293 cells, EMBO J. 19 (2000) 942–955.
[21] J. Mao, X. Wang, F. Chen, R. Wang, A. Rojas, Y. Shi, H. Piao, C. Jiang,
Molecular basis for the inhibition of G protein-coupled inward rectifier
K(+) channels by protein kinase C, Proc. Natl. Acad. Sci. U. S. A. 101
(2004) 1087–1092.
[22] E.B. Stevens, B.S. Shah, R.D. Pinnock, K. Lee, Bombesin receptors inhibit
G protein-coupled inwardly rectifying K+ channels expressed in Xenopus
oocytes through a protein kinase C-dependent pathway, Mol Pharmacol.
55 (1999) 1020–1027.
[23] D. Vorobiov, G. Levin, I. Lotan, N. Dascal, Agonist-independent
inactivation and agonist-induced desensitization of the G protein-activated
K+ channel (GIRK) in Xenopus oocytes, Pflugers Arch. 436 (1998)
56–68.
[24] L. Zhang, J.K. Lee, S.A. John, N. Uozumi, I. Kodama, Mechanosensitivity
of GIRK channels is mediated by protein kinase C-dependent channel-
phosphatidylinositol 4,5-bisphosphate interaction, J. Biol. Chem. 279
(2004) 7037–7047.
[25] G. Zhu, Z. Qu, N. Cui, C. Jiang, Suppression of Kir2.3 activity by protein
kinase C phosphorylation of the channel protein at threonine 53, J Biol.
Chem. 274 (1999) 11643–11646.
[26] E. Zitron, C. Kiesecker, S. Luck, S. Kathofer, D. Thomas, V.A. Kreye, J.
Kiehn, H.A. Katus, W. Schoels, C.A. Karle, Human cardiac inwardly
rectifying current Kir2.2 is upregulated by activation of protein kinase A,
Cardiovasc. Res. 63 (2004) 520–527.
[27] L. Li, A. Rojas, J. Wu, C. Jiang, Disruption of glucose sensing and insulin
secretion by ribozyme Kir6.2-gene targeting in insulin-secreting cells,
Endocrinology 145 (2004) 4408–4414.
[28] J. Wu, N. Cui, H. Piao, Y. Wang, H. Xu, J. Mao, C. Jiang, Allosteric
modulation of the mouse Kir6.2 channel by intracellular H+ and ATP,
J. Physiol. 543 (2002) 495–504.
[29] G. Zhu, Y. Zhang, H. Xu, C. Jiang, Identification of endogenous outward
currents in the human embryonic kidney (HEK 293) cell line, J. Neurosci.
Methods 81 (1998) 73–83.
[30] E. Wischmeyer, A. Karschin, Receptor stimulation causes slow inhi-
bition of IRK1 inwardly rectifying K+ channels by direct protein kinase
A-mediated phosphorylation, Proc. Natl. Acad. Sci. U. S. A. 93 (1996)
5819–5823.
[31] X. Du, H. Zhang, C. Lopes, T. Mirshahi, T. Rohacs, D.E. Logothetis,
Characteristic interactions with phosphatidylinositol 4,5-bisphosphate
determine regulation of kir channels by diverse modulators, J. Biol.
Chem. 279 (2004) 37271–37281.
[32] C.M. Lopes, H. Zhang, T. Rohacs, T. Jin, J. Yang, D.E. Logothetis,
Alterations in conserved Kir channel-PIP2 interactions underlie channe-
lopathies, Neuron 34 (2002) 933–944.
[33] D. Lin, H. Sterling, K.M. Lerea, G. Giebisch, W.H. Wang, Protein kinase C
(PKC)-induced phosphorylation of ROMK1 is essential for the surface
expression of ROMK1 channels, J. Biol. Chem. 277 (2002) 44278–44284.
[34] H. Sterling, D.H. Lin, R.M. Gu, K. Dong, S.C. Hebert, W.H. Wang,
Inhibition of protein-tyrosine phosphatase stimulates the dynamin-
dependent endocytosis of ROMK1, J. Biol. Chem. 277 (2002) 4317–4323.
2042 A. Rojas et al. / Biochimica et Biophysica Acta 1768 (2007) 2030–2042[35] W.H. Wang, D.H. Lin, H. Sterling, Regulation of ROMK channels by
protein tyrosine kinase and tyrosine phosphatase, Trends Cardiovasc. Med.
12 (2002) 138–142.
[36] W.H. Wang, Regulation of ROMK (Kir1.1) channels: new mechanisms
and aspects, Am. J. Physiol., Renal. Physiol. 290 (2006) F14–F19.
[37] W.Z. Zeng, V. Babich, B. Ortega, R. Quigley, S.J. White, P.A. Welling,
C.L. Huang, Evidence for endocytosis of ROMK potassium channel
via clathrin-coated vesicles, Am. J. Physiol. Renal. Physiol. 283 (2002)
F630–F639.
[38] P. Beguin, K. Nagashima, M. Nishimura, T. Gonoi, S. Seino, PKA-
mediated phosphorylation of the human K(ATP) channel: separate roles
of Kir6.2 and SUR1 subunit phosphorylation, EMBO J. 18 (1999)
4722–4732.
[39] H. Hibino, Y. Horio, A. Fujita, A. Inanobe, K. Doi, T. Gotow, Y.
Uchiyama, T. Kubo, Y. Kurachi, Expression of an inwardly rectifying K(+)
channel, Kir4.1, in satellite cells of rat cochlear ganglia, Am. J. Physiol.
277 (1999) C638–C644.
[40] H. Hibino, A. Fujita, K. Iwai, M. Yamada, Y. Kurachi, Differential
assembly of inwardly rectifying K+channel subunits, Kir4.1 and Kir5.1, in
brain astrocytes, J. Biol. Chem. 279 (2004) 44065–44073.[41] K. Higashi, A. Fujita, A. Inanobe, M. Tanemoto, K. Doi, T. Kubo, Y.
Kurachi, An inwardly rectifying K(+) channel, Kir4.1, expressed in
astrocytes surrounds synapses and blood vessels in brain, Am. J. Physiol.,
Cell Physiol. 281 (2001) C922–C931.
[42] M. Ito, A. Inanobe, Y. Horio, H. Hibino, S. Isomoto, H. Ito, K. Mori, A.
Tonosaki, H. Tomoike, Y. Kurachi, Immunolocalization of an inwardly
rectifying K+ channel, K(AB)-2 (Kir4.1), in the basolateral membrane of
renal distal tubular epithelia, FEBS Lett. 388 (1996) 11–15.
[43] S. Kusaka, Y. Horio, A. Fujita, K. Matsushita, A. Inanobe, T. Gotow, Y.
Uchiyama, Y. Tano, Y. Kurachi, Expression and polarized distribution of
an inwardly rectifying K+channel, Kir4.1, in rat retinal pigment epithelium,
J. Physiol. 520 (Pt. 2) (1999) 373–381.
[44] H. Xu, Z. Yang, N. Cui, L.R. Giwa, L. Abdulkadir, M. Patel, P. Sharma, G.
Shan, W. Shen, C. Jiang, Molecular determinants for the distinct pH
sensitivity of Kir1.1 and Kir4.1 channels, Am. J. Physiol. Cell Physiol. 279
(2000) C1464–C1471.
[45] H. Xu, Z. Yang, N. Cui, S. Chanchevalap, W.W. Valesky, C. Jiang, A single
residue contributes to the difference between Kir4.1 and Kir1.1 channels in
pH sensitivity, rectification and single channel conductance, J. Physiol.
528 (Pt. 2) (2000) 267–277.
